TRML: Tourmaline Bio Inc Kompaniya qiymatining sof foydaga nisbati
Tourmaline Bio, Inc. (TRML) noyob immun patologiyalari uchun terapiya vositalarini ishlab chiqishda ilmiy markazlar bilan hamkorlik qilmoqda. O'zlashtirilmagan yo'nalishlardagi antitanalarning kuchli patent himoyasi yuqori daromadlilikni kafolatlaydi. Biroq, muvaffaqiyat yagona aktivga va kapitalning mavjudligiga bog'liq. P/E koeffitsiyenti tendentsiyasi kompaniyaning bozor qiymatini baholashga yordam beradi, bunda -14.10 ushbu metrikaning joriy qiymatini ko'rsatadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261111&filename=GURU_Markets_-_TRML_-_Tourmaline-Bio-Inc._-_PE-Multiple "TRML: Tourmaline Bio, Inc. Biznesning o‘zini qoplash muddati 21.02.2024 - 08.11.2025 | 👁️GURU.Markets👁️")
Tourmaline Corp (TRML) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Tourmaline Bio, Inc.|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Tourmaline|TRML - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Tourmaline Bio, Inc.|TRML - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Tourmaline Bio|Oraliq likvidlik koeffitsiyenti tourmalinebio.com
- foyda va bozor multiplikatorlari tafsilotlari:
TRML - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Tourmaline Bio, Inc.|TRML - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Tourmaline Bio Inc|TRML - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Tourmaline Bio, Inc.|TRML - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Tourmaline Bio|TRML - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi tourmalinebio.com|TRML - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Tourmaline Bio, Inc.
Kompaniyaning har tomonlama tahlili:tourmalinebio.com TRML
Tourmaline Bio, Inc. (TRML) kompaniyasining immun patologiyalari uchun noyob terapiya usullariga ixtisoslashganligi biznesning yuqori baholanish premiumini ta'minlaydi, bu esa bozor kapitalizatsiyasining sof foydaga nisbatida aks etadi. Ushbu koeffitsient investitsiyalarning qoplanish muddatini o'lchaydi va kompaniyaning o'rtacha P/E ko'rsatkichi orqali bozor kutuvlari va haqiqiy moliyaviy natijalar o'rtasidagi joriy muvozanatni baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|Precigen Corp - Bozor narxining sof foydaga nisbati|Pharming Group N.V. (PHAR) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati nektar.com (NKTR)|Narx-foyda koeffitsiyenti UPB|P/E multiplikatori Zenas Bio|Narxning foydaga nisbati Immunome Corp (IMNM)|GOSS (Gossamer Bio Corp.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati KalVista Pharmaceuticals KALV|SEPN - Narx-foyda koeffitsiyenti|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB (AnaptysBio Inc.) - Narxning foydaga nisbati|ATXS (Astria Therapeutics) - P/E multiplikatori|engene.com (ENGN) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|aerovatetx.com - Narx-foyda multiplikatori|P/E multiplikatori ACRS (Aclaris)|Kyverna Therapeutics, Inc (KYTX) - Kapitalizatsiyaning foydaga nisbati|TLSA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CABA (cabalettabio.com)|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc.) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|Eledon Pharmaceuticals, Inc (ELDN) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Agenus (AGEN)|CLYM - Kapitalizatsiyaning foydaga nisbati|Zura Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ATYR|Adagene Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati ImageneBio Inc IMA|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda multiplikatori EQ|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Narx-foyda koeffitsiyenti Immunic Inc (IMUX)|Narx-foyda koeffitsiyenti ATRA (Atara Biotherapeutics)|Biznesning o‘zini qoplash muddati inflarx.de|X4 Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACET (Adicet Bio Inc.)|CELU - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|Narxning foydaga nisbati SAB Biotherapeutics|Narxning foydaga nisbati AKTX|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|QTTB: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Kompaniya qiymatining sof foydaga nisbati EDSA|iBio, Inc. - P/E multiplikatori|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|GRI Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
